Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Bloomberg Markets

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
ShareXFacebook

Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.

B

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement